Back to results

ETH Zurich

Engineered cytokine derivatives for targeted cancer immunotherapy

dc:creator Venetz, Dario

dc:date2016

Degree

thesis:*

Grantor dc:publisher: ETH Zurich
Year dc:date: 2016

Author and committee

dc:creator, dc:contributor.*

Author dc:creator: Venetz, Dario
Contributors dc:contributor: Neri, Dario; id_orcid0000-0001-5234-7370
Halin, Cornelia

Subjects

dc:subject × 3

KREBSTHERAPIE + TUMORTHERAPIE (MEDIZIN); IMMUNPHARMAKOLOGIE + IMMUNTHERAPIE + IMMUNPROPHYLAXE + IMMUNOLOGISCHE PRÄPARATE; ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); ZYTOKINE (IMMUNOLOGIE); MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN); INTERLEUKIN-12 (IMMUNOLOGIE); ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG; CANCER TREATMENT + TUMOUR TREATMENT (MEDICINE); IMMUNOTHERAPY + IMMUNOPHARMACOLOGY + IMMUNOLOGIC MEDICAMENTS + IMMUNOPROPHYLACTIC AGENTS; TARGETED DRUGS (PHARMACOLOGY); CYTOKINES (IMMUNOLOGY); MONOCLONAL ANTIBODIES (IMMUNOLOGICAL TECHNIQUES); INTERLEUKIN-12 (IMMUNOLOGY); DRUG DEVELOPMENT + DRUG DESIGN + DRUG DISCOVERY (PHARMACY)
info:eu-repo/classification/ddc/610
Medical sciences, medicine

Rights

dc:rights

Statement dc:rights: info:eu-repo/semantics/openAccess

In Copyright - Non-Commercial Use Permitted
Licence: http://rightsstatements.org/page/InC-NC/1.0/
Language dc:language: en

Identifiers

dc:identifier.*

Identifier: https://doi.org/10.3929/ethz-a-010792885
OAI identifier oai:identifier: oai:www.research-collection.ethz.ch:20.500.11850/156048

Chain of custody

source

Harvested from: ETH Zürich
Base URL: www.research-collection.ethz.ch/oai/request
Last updated: 2026-07-27
Source record: OAI-PMH GetRecord

related terms

citation

Venetz, Dario. Engineered cytokine derivatives for targeted cancer immunotherapy. ETH Zurich, 2016. http://hdl.handle.net/20.500.11850/156048

More from ETH Zürich